The effect of phenothiazines (trifluoperazine and chlorpromazine) on cholesteryl ester metabolism has been investigated in J 774 mouse monocyte-macrophages. The incorporation of oleic acid into cholesteryl ester and the activity of acylcoenzyme A : cholesterol-O-acyltransferase were strongly decreased in cells pretreated for 24 h with trifluoperazine or chlorpromazine. Furthermore, trifluoperazine or chlorpromazine decreased the degradation of acetylated low density lipoprotein by J 774 cells. When cell homogenates were preincubated in vitro with trifluoperazine or chlorpromazine, a marked inhibition of acylcoenzyme A : cholesterol-O-acyltransferase activity was observed. In cells incubated with acetylated low density lipoprotein loaded with radiolabeled cholesteryl-linoleate, trifluoperazine and chlorpromazine dramatically reduced the radioactivity recovered in cholesteryl esters. The radioactivity recovered in free cholesterol was also decreased, but to a lesser extent. These results suggest that phenothiazines could efficiently antagonize cholesteryl ester accumulation in macrophages by at least two different mechanisms: a reduction of modified LDL catabolism, and a direct inhibition of the enzyme acylcoenzyme A : cholesterol-O-acyltransferase.
Introduction
, , , ,.,-,,. l esteryl esters occurs because modified LDL uptake Atherosclerotic lesions have been demonstrated to be is not down-regulated (4) . This process is currently infiltrated by foam cells derived from monocyte-mac-believed to be closely involved in the appearance of rophages overloaded with cholesteryl esters (1) . Mah-atherosclerotic lesions (1) . ley et al. (2) and Goldstein et al. (3) reported the existence of receptors for modified low-density lipo-We previously reported a biphasic effect of phenothiproteins (LDL), such as acetylated LDL, at the sur^ azines such as trifluoperazine and chlorpromazine on face of macrophages, and such receptors have also LDL and sterol metabolism in human fibroblasts (5, been found in monocytes by Fogelman et al. (4) . 6). We demonstrated that these drugs are potent inUptake of modified LDL by monocyte-derived mac-hibitors of cholesterol esterification in fibroblasts (6) . rophages leads to massive accumulation of cholesteryl Such an effect has been also reported for chlorpromesters, due to a dramatic increase in acylcoenzyme A azine in another experimental model, the arterial wall, : cholesterol-O-acyltransferase activity (2) (3) (4) . Over-by Bell (7, 8) . In view of the fact that cholesteryl ester loading of monocyte-derived macrophages with cho-accumulation is closely involved in atherogenesis, it was of interest to investigate the effect of phenothiazines on cholesterol esterification in the monocytemacrophage. In the present work, we demonstrated a strong inhibition of cholesteryl ester formation by trifluoperazine and chlorpromazine in J 774 mouse monocyte-like cells. The reaction was carried put for 5 minutes at 37 °C and stopped on ice. An aliquot of the incubation mixture was then put on a silica gel plate, and neutral lipids were separated by thin layer chromatography as described above. Spots corresponding to cholesteryl ester were cut out and the radioactivity was counted by liquid scintillation. Acylcoenzyme A : cholesteroUO-acyltransferase activity was expressed as nmol/h · mg of cell protein.
Materials and Methods

Materials
Metabolism of cholesteryl linoleate-labeled LDL
Cells were preincubated for 24 h in Dulbecco's MEM medium supplemented with foetal calf serum, volume fraction 0.1, in the absence or in the presence of trifluoperazine or chlorpromazine 10 μπιοΐ/ΐ. Acetylated LDL labeled with [ 3 H]cholesteryl linoleate was then added at a concentration of 10 mg/1. After a further 24 h incubation at 37 °C, cells were washed 4 times with a phosphate-buffered solution pH 7.4, harvested with rubber policemen, and centrifuged; lipid analysis was performed on aliquots of the cell suspension after direct application to silica gel plates as previously described (15) . The solvent system was hexane/diethylether/acetic acid 70/30/2 (by vol.). After autoradiography, lipids were identified by comparison with purified standards (Sigma). Spots corresponding to cholesterol and cholesteryl esters were cut out and their radioactivity measured by liquid scintillation in an Intertechnique instrument. Results are expressed in fmol of [ Table 1 presents the effect of trifluoperazine and chlorpromazine on [ fluoperazine or chlorpromaziiie, the decrease was about 70% or 65%, respectively. [
Results
14 C]oleic acid incorporation into triacylglycerols, taken as an internal control, was not significantly affected. 
From these results, it is concluded that phenothiazines either directly inhibit acylcoenzyme A : cholesterol-O-acyltransferase, or/and decrease its activity indirectly by affecting acetylated LDL metabolism, since it is known that the acylcoenzyme A : cholesterol-Oacyltransferase activity of maerophages is highly dependent on the uptake and degradation of modified LDL (2, 3) . In order to investigate these possibilities, we further studied the effect of phenothiazines on acetylated LDL catabolism by J 774 cells. Table 3 shows that both trifluoperazine and chlorpromazine decreased [ 125 I]acetylated LDL degradation by J 774 cells, with about 60% and 55% reduction for trifluoperazine and chlorpromazine (10 μιηοΐ/ΐ), respectively. Concomitantly, the intracellular radioactivity, corresponding to undegraded acetylated LDL, was markedly increased in both cases. The total radioactivity (intracellular + degraded) remained unchanged, indicating that the increased intracellular radioactivity merely reflected the reduced lysosomal degradation.
We also investigated the possibility of a direct inhibition of the acylcoenzyme A : cholesterol-O-acyltransferase activity by phenothiazines, in experiments performed with homogenates of untreated J 774 cells submitted to a short in vitro preincubation at 37 °C in the presence of the drugs. Table 4 shows that under these conditions, chlorpromazine and trifluoperazine also decreased the acylcoenzyme A : cholesterol-Oacyltransferase activity, although higher concentra- tions of drugs must be utilized to observe a significant effect: about 50% decrease was observed both for chlorpromazine or trifluoperazine (100 μηιοΐ/ΐ), and about 80% decrease was noted at 500 μηιοΐ/ΐ.
It was also of interest to investigate the effects of phenothiazines on the metabolism of exogenous cholsteryl esters introduced into cells by means of the scavenger receptor pathway. We thus loaded acetylated LDL with cholesteryl linoleate labelled in the cholesterol moiety and measured the radioactivity recovered in free and esterified cellular cholesterol after a 24 h incubation of J 774 cells with radioactive acetylated LDL. The results are shown in table 5. Trifluoperazine or chlorpromazine (10 μιηοΐ/ΐ) strongly decreased the radioactivity recovered in cholesteryl esters after a 24 h incubation with cholesteryl linoleate-labeled acetylated-LDL. It can be seen that the radioactivity recovered in free cholesterol was less affected, with about 20-30% decrease compared with the control. The total radioactivity recovered in cholesterol (free + esterified) was decreased about 50% and 40% in the presence of trifluoperazine or chlorpromazine (10 μπιοΐ/ΐχ respectively.
Discussion
This work demonstrates that phenothiazines strongly inhibit oleic acid incorporation into cholesteryl esters and acyl coenzyme A : cholesterol-O-acyltransferase activity in J 774 monocyte-like cells. This effect appears to involve at least two mechanisms: a reduction of acetylated LDL degradation (tab. 3), and a direct inhibition of the enzyme acyl coenzyme A : cholesterol-O-acyltransferase (tab. 4). In previous studies, Bell reported that chlorpromazine inhibited cholesterol esterification in arterial tissue and isolated arterial microsomes (8) . Acylcoenzyme A : cholesterol-O-acyltransferase activity of isolated arterial microsomes was diminished in vitro by about 50% in the presence of 100 μπιοΐ/ΐ chlorpromazine and by more than 95% at 1 mmol/1 (8) . These values are close to that found in our experiments. More recently, Stein & Stein (17) demonstrated that verapamil, another calcium antagonist drug, inhibited cholesterol esterification in the J 774 cell line. However, these authors did not find a direct effect of this drug on the acylcoenzyme A : cholesterol-O-acyltransferase activity, and concluded that this inhibition could be related to an impaired lysosornal hydrolysis of exogenous cholesteryl ester and a subsequent decrease in the delivery of free cholesterol to the site of acylcoenzyme A : cholesterol-O-acyltransferase regulation.
The inhibitory effect of phenothiazines on the degradation of acetylated LDL by J 774 cells is probably related to the antagonistic effect of these drugs on calmodulin-dependent mechanisms. In previous studies, Van Berkel et al. demonstrated a reduction of acetylated LDL catabolism by trifluoperazine in another experimental system, the rat liver non-parenchymal cell (18) . In fibroblasts, we also found a strong inhibition of native LDL degradation by calmodulin antagonists such as trifluoperazine-or calmidazolium (5). These effects are probably dire to an interaction of the drugs with some cytoskeleton components involved in the endocytic processes, leading to a decrease in acetylated LDL delivery to lysosomes.
The mechanism by which phenothiazines directly inhibit the acylcoenzyme A : cholesterol-O-acyltransferase activity is probably related to alterations in the membrane ultrastructure, and especially in the physical state of membrane lipids: various amphiphilic compounds exhibiting local anaesthetic properties are able to inhibit acylcoenzyme A : cholesterol-O-acyltransferase activity (19) . Interaction of amphiphilic compounds with membrane phospholipids, with a subsequent increase in membrane fluidity, has been reported in several experimental systems (20, 21) . As acylcoenzyme A : cholesterol-O-acyltransferase appears to be very sensitive to alterations of its microsomal membrane microenvironment (22) , it is likely that the inhibition of this enzyme activity could be related to the interaction of phenothiazines with cellular membranes. The dramatic reduction by chlorpromazine and trifluoperazine of the re-esterification of cholesterol entering via the acetylated LDL pathway is of particular interest. This results in a strong reduction of the radioactivity recovered in the cholesteryl ester fraction, and also in a decrease of the total cell-bound radioactivity (free + esterified cholesterol). This might be due to a stimulation of cholesterol efflux from the monocyte-macrophage cell, since the slow calcium channel blocker, nifedipine, has been reported to promote cholesterol efflux from mouse peritoneal rnacrophages (23) .
The inhibitory effect of phenothiazines on cholesterol esterification has not yet been reported in the monocyte-macrophages. This phenomenon may be of great interest in view of the fact that cholesteryl ester accumulation is currently believed to be one of the main features involved in the formation of atherosclerotic lesions (1) . Massive cholesteryl ester accumulation in monocyte-derived rnacrophages is due to the nondown-regulated uptake of LDL, probably modified by oxidative processes (24) . These modifications are the result of a decreased turnover of the LDL in subjects presenting a defect in the apolipoprotein B/Especific receptor pathway, which results in an increased half-life of the LDL in plasma. It would therefore be of interest to reduce cholesteryl ester accumulation in monocyte-macrophages: this may be an alternative way of preventing atherogenesis. At present, the therapeutics of atherogenesis in heterozygous subjects with familial hypercholesterolaemia are mainly based on the induction of the apolipoprotein B/E receptor by inhibitors of cholesterol synthesis such as mevinolin (25) , and inhibitors of intestinal bile acid reabsorption such as cholestyramine (26) . But it must be emphasized that such therapeutics only result in a moderate increase in LDL catabolism by the specific receptor pathway, and that they do not act on the process directly involved in atherogenesis, e. g. cholesteryl ester accumulation by macrophages. Moreover, inhibitors of cholesterol synthesis evidently fail to accelerate LDL turnover in homozygous subjects with familial hypercholesterolaemia. In this case, the only steps which can be influenced by therapeutic agents are cholesterol synthesis and cholesteryl ester accumulation by macrophages. The use of amphiphilic cationic drugs especially designed for this purpose may therefore have interesting therapeutic possibilities.
